Nmc Health Share Discussion Threads

[yertiz] 20/12/2018 10:52

Buying opportunity - the business model hasn't gone bad overnight, time to add a few k's worth methinks.

[mfhmfh] 20/12/2018 09:22

surprised at the fall here.

[smartinvest1] 17/12/2018 13:03

Directors think that by buying shares they can fool the other investors.

[smartinvest1] 17/12/2018 13:03

Directors think that by buying shares they can fool the other investors.

[1amb] 15/12/2018 21:38

Last week £760 k purchase of NMC by three directors is a strong positive for the share price, indicating insider confidence that current price levels is a buying opportunity.

[malcolmmm] 10/12/2018 09:44

Analysts are usually wrong, most have irons in the fire , conflicts of interest so they are biased imo

[smartinvest1] 06/12/2018 13:52

I am not a shoet seller. I am a story teller. Market can go up and down

[daijavu] 05/12/2018 21:40

mdr26niz.

smartinvest might not be totally wrong. The murder could easily lead to further instability in the Middle East. That could impact on Israel and affect investor sentiment about Plus merely because Plus is based in Israel. Whether that is a reason for concern for the stock is another matter.

[mdr26nlz] 04/12/2018 10:03

at some posts smartinvest looked resonable, untill he wrote that the murder of the journalist in turkey is a reason of concern for this stock... really?

[plexus1] 04/12/2018 06:00

@ smartinvest1 - of course you are, you are a short seller only wishing for the destruction of this stock, as reflected in all your previous posts.

[volsung] 29/11/2018 10:15

Against this -ve background I have bought in

[smartinvest1] 28/11/2018 09:03

Totally agree with jeferies. The receivable figure in the balance sheet is 500 million usd which is very high. Also the insurance companoes take time to pay some pays after 6 months.

[steeplejack] 28/11/2018 08:53

Jefferies has adopted a more cautious approach to blue chip NMC Health, cutting its rating to 'underperform' over a range of concerns, including corporate governance.The bank said that NMC, a healthcare provider based in the United Arab Emirates and listed in London, was "a well-loved story".It continued: "Attractive healthcare fundamentals in the UAE, expansion of the highly profitable IVF segment and close ties to the Saudi government ahead of anticipated privatisation, all translate into double-digit earnings growth on which there is little to no to no tax."But Jefferies had "concerns", including "increasing risks if the company continues on the same path, down which it looks to be accelerating with the recent Aspen and GOSI deals. Hence we believe the market is overestimating the value-creation potential."Other concerns flagged by Jefferies include NMC's expansion into Saudi Arabia, where there is higher reliance on government pay, declining expat population as well as competition from established players.The analysts also highlighted corporate governance concerns with "an increasing focus on EBITDA in both STIP and LTIP and the removal of EPS to be alarming, especially given net income as a percentage of EBITDA has declined from 78% to 53% in 2012-17" and hoped measures will be "addressed by the remuneration committee".Jefferies cut its price target for NMC to 2,940p from 3,411p.

[arja] 27/11/2018 10:21

amazing how one analyst's comment can knock an share price but it is usually only a short term effect. But in a shaky market with the brexit disaster effect , the drop is even worse than it would have been . It will be a shorters market for quite some time unless we stay in the EU .

[aishah] 27/11/2018 09:44

Jefferies downgrades to UNDERPERFORM with 2940p target. Happy to hold here.

[kikkeridirect] 27/11/2018 09:28

Why the weakness in share price today ?

[steeplejack] 22/11/2018 11:36

UAE healthcare provider NMC Health surged on Wednesday as JPMorgan Cazenove said it continues to be a strong growth story thanks to a mix of organic initiatives and aggressive M&A activity and bumped the stock up to 'overweight' from 'neutral', hiking the price target to 4,265p from 3,450pThe bank noted that NMC has deployed $472m on 14 transactions since the beginning of the year and spent a total of about $2bn on acquisitions over the last three years."Without factoring in any new M&A activity, its medium-term outlook looks impressive with net earnings growing at a three-year compound annual growth rate of 36% between 2017 and 2020 on our numbers," it said.JPM attributed the price target increase to upgraded forecasts and a change to the relative valuation method, as it ow values the healthcare and distribution business separately.It estimated that between its cash balance as of H1 2018, free cash flow generation and additional debt, NMC could deploy another $1bn on M&A activity over the next 18 months."We expect M&A activity to target general healthcare facilities when attractive propositions arise, but also underserved services such as IVF, LT Care, Cosmetic, Paediatric, Oncology, Mental Health, and Rehabilitation."

[alphabeta4] 21/11/2018 16:27

I was right JP Morgan and Merrill Lynch have positive notes out.

[alphabeta4] 21/11/2018 11:27

Quite possibly, I suspect there could also be a note out somewhere - I know Barclays two days ago wrote about it being one of their top European buys (delayed reaction?).

Furthermore, with the tech weakness growth investors are left a little bit stuck of where to park their money - you can't get much more defensive than healthcare.

[steeplejack] 21/11/2018 09:06

I presume this leap in price is on the likelihood that Saudi won't be punished by Trump.

[smartinvest1] 05/11/2018 11:03

I belive the managemwnt is only talking about the positive numbers as significant number of the shares of promoters are pledged or strutured.

[smartinvest1] 26/10/2018 07:28

Its a big gamble to go to saudi market. Anytime sanctions csn happen.Also funding cost is very high difgicult to make money.

[blocker2] 23/10/2018 09:29

Daily Telegraph business insight section today.

[rampmeister] 22/10/2018 14:27

I like the update. We can expect revenue growth approaching 50% and higher profit margin over the next 18 months. Think these forecasts are likely to prove conservative giving them opportunity to surprise on the upside going forward.

RM

[steeplejack] 22/10/2018 11:34

Very wise in view of the international furore surrounding Saudi Arabia.